Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BHP takes up stake in Cobre's Botswana projects

(Sharecast News) - Mining giant BHP has taken a stake in Australian outfit Cobre's Kitlanya projects in Botswana in exchange for as much as USD $25.0m in funding for the exploration of copper-silver deposits. BHP's investment focuses on Cobre's East and West Kitlanya copper projects on the margins of the Kalahari Copper Belt and will see it put in a minimum of USD $5.0m within two years, with a budget of USD $7.0m for exploration of the Kitlanya projects, beginning in April.

The exploration, which comes hot on the heels of Cobre's participation in BHP's 2024 Xplor programme, will include deep diamond drilling and 2D seismic surveys as the pair look to evaluate Kitlanya's mineral system for Tier 1 copper deposits. Drilling mobilisation was set for April, targeting areas identified in the 2024 Xplor seismic programme.

BHP will also have the option to earn a 75% interest in the Kitlanya projects by investing $25.0m, including the initial $5.0m, while Cobre Botswana will serve as the operator during the earn-in phase, receiving an annual management fee of no less than USD $250,000.

As of 0920 GMT, BHP shares were down 0.91% at 1,901.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.